Programmed Cell Death Ligand 1 Expression in Circulating Tumor Cells as a Predictor of Treatment Response in Patients with Urothelial Carcinoma

Programmed cell death ligand 1 (PD-L1) inhibitors are commonly used in treating advanced-stage urothelial carcinoma (UC). Therefore, this study evaluated the relationship between PD-L1 expression in circulating tumor cells (CTCs) and treatment response to PD-L1 inhibitors using blood samples collect...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Pei-Jhang Chiang, Ting Xu, Tai-Lung Cha, Yi-Ta Tsai, Shu-Yu Liu, Sheng-Tang Wu, En Meng, Chih-Wei Tsao, Chien-Chang Kao, Chin-Li Chen, Guang-Huan Sun, Dah-Shyong Yu, Sun-Yran Chang, Ming-Hsin Yang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2021-07-01
Colecção:	Biology
Assuntos:	urothelial carcinoma circulating tumor cells PD-L1 PD-L1 inhibitors
Acesso em linha:	https://www.mdpi.com/2079-7737/10/7/674
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!